483 Rubicon Research Private Apr 2013

483 Rubicon Research Private Apr 2013

$119 - Not in Stock

FDA investigators audited the Rubicon Research Private - Ambernath, India facility and issued inspectional observations (via FDA 483) on 11 Apr 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 11 Apr 2013
  • Location: Ambernath, India
  • FEI: 3008252295

Pre-Order Not Available